Human C-reactive protein induces endothelial dysfunction in biobreeding diabetic rats

Area of Science:

• Cardiovascular Research
• Endocrinology
• Immunology

Background:

• C-reactive protein (CRP) is a marker of inflammation and predicts cardiovascular events in diabetes.
• Human CRP (hCRP) has been shown to exacerbate proinflammatory, pro-oxidant, and procoagulant states in a type 1 diabetes mellitus (T1DM) rat model.
• Limited data exists on CRP's role in endothelial dysfunction in animal models of diabetes.

Purpose of the Study:

• To investigate the effect of human CRP (hCRP) on endothelial dysfunction in a spontaneous model of type 1 diabetes mellitus (T1DM).
• To determine if hCRP administration induces changes in specific biomarkers associated with endothelial dysfunction in diabetic rats.

Main Methods:

• Diabetic biobreeding (BB) rats were administered either human serum albumin (HSA) or hCRP intraperitoneally for three consecutive days.
• Plasma levels of endothelin-1 (ET-1), soluble intracellular adhesion molecule-1 (sICAM-1), Von Willebrand factor (vWF), and 6-keto prostaglandin F1-alpha (6-keto PGF1-α) were measured.
• A sample size of n=4 rats per group was used.

Main Results:

• hCRP administration significantly increased circulating levels of ET-1, vWF, and sICAM-1 in diabetic rats compared to HSA-treated controls.
• No significant effect of hCRP was observed on plasma levels of 6-keto PGF1-α.
• These results indicate hCRP induced markers of endothelial dysfunction.

Conclusions:

• Human CRP induces endothelial dysfunction in a spontaneous model of T1DM.
• This finding suggests a potential mechanism linking CRP to vascular complications in diabetic patients.
• Further research is warranted to explore therapeutic strategies targeting CRP in diabetes.